Clinical trial • Phase I • Oncology
PF-08046876 for Advanced solid tumors
Phase I trial of PF-08046876 for Advanced solid tumors. None/Not specified-controlled. 240 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase I
Key dates
- Initial CTIS Submission Date
- 03-09-2025
- First CTIS Authorization Date
- 23-12-2025
Trial design
None/Not specified-controlled Phase I trial across 3 sites in Spain.
- Comparator
- None/Not specified
- Target Sample Size
- 240
- Trial Duration For Participant
- 1342
Eligibility
Recruits 240 Vulnerable population not selected; no special consent/assent handling described..
- Vulnerable Population
- Vulnerable population not selected; no special consent/assent handling described.
Recruitment
- Planned Sample Size
- 240
- Recruitment Window Months
- 44
Geography
- Total Number Of Sites
- 3
- Total Number Of Participants
- 240
Spain
- Earliest CTIS Part Ii Submission Date
- 25-11-2025
- Latest Decision Or Authorization Date
- 23-12-2025
- Processing Time Days
- 28
- Number Of Sites
- 3
- Number Of Participants
- 70
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Medical Oncology
- Principal Investigator Name
- Guillermo de Velasco Oria de Rueda
- Principal Investigator Email
- gdevelasco.gdv@gmail.com
- Contact Person Name
- Guillermo de Velasco Oria de Rueda
- Contact Person Email
- gdevelasco.gdv@gmail.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Departamento de Oncologia- VHIO
- Principal Investigator Name
- Elena Garralda Cabanas
- Principal Investigator Email
- egarralda@vhio.net
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Medical Oncology
- Principal Investigator Name
- Bernard Gaston Doger de Speville Uribe
- Principal Investigator Email
- Bernard.doger@startmadrid.com
- Contact Person Name
- Bernard Gaston Doger de Speville Uribe
- Contact Person Email
- Bernard.doger@startmadrid.com
Sponsor
Primary sponsor
- Full Name
- Pfizer Inc.
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- United States
Investigational products
- Investigational Product Name
- PF-08046876
Related trials
Other published trials that may interest you.